Potassium iodide Renewal Tablets 200mkg, # 112

Potassium iodide tab.

200mkg No. 112 Renewal

Name ENG

POTASSIUM IODIDE

Clinical and pharmacological group

Iodine preparation for the prevention and treatment of thyroid diseases

ATX code

Iodine preparations

Dosage

200μg

Structure

1 tab .: potassium iodide 262 mcg incl.

iodine 200 mcg

Indications

Prevention and treatment of endemic goiter.

Prevention of goiter recurrence during complex treatment with thyroid hormone preparations.

Storage conditions and periods

In a dark place at a temperature not exceeding 25 degrees.

Expiration date: 3 years

Contraindications

Severe hyperthyroidism, latent hyperthyroidism (when used in doses exceeding 150 mcg / day), toxic adenoma, nodular or diffuse toxic goiter (when used in doses of 300-1000 mcg / day), dermatitis herpetiformis (Duhring's disease), pregnancy and breastfeeding (when used in doses of 1-2 mg / day), hypersensitivity to iodine preparations.

INN / Active ingredient

Potassium iodide

Specifications

Category

Thyroid

Scope of the drug

Endocrine system

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

112

Scope of application

Endocrinology

Minimum age from

From birth

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

PFC update

The amount of the dosage form in the primary package

14 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Thyroxine synthesis regulator - iodine drug

Anatomical and therapeutic characteristics

H03CA Iodine preparations

Dosage form

Pills

Packaging

Box

Expiration date in days

1095

The target audience

Children

Dosage (volume) of the substance in the preparation

262 μg

Package weight, g

thirty

Mode of application

:

Inside, after eating, with plenty of liquid.

Goiter treatment for adults and children over 12 years old - 300-500 mcg / day, for children under 12 years old - 100-200 mcg / day.

For the prevention of goiter in case of iodine deficiency: adults and children from 12 years old - 100-200 μg / day, children under 12 years old (including newborns) - 50-100 μg / day, pregnant and lactating women - 150-200 μg / day

Prevention of relapse after therapeutic treatment of iodine-deficient goiter - 100-200 μg / day.

After surgical treatment of goiter in newborns, children and adolescents - 100-200 mcg / day.

The duration of treatment is determined by the doctor

prophylactically for adults is usually prescribed for several months, years or a lifetime

children and adolescents - usually within 6-12 months.